Latest & greatest articles for insomnia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on insomnia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on insomnia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for insomnia

381. Provent sleep apnea therapy (Ventus Medical Inc.) for obstructive sleep apnea

. Lansdale: HAYES, Inc.. Healthcare Technology Brief Publication Dates. 2011 Authors' conclusions Obstructive sleep apnea (OSA) is a breathing disorder that is defined by either a decrease or complete cessation of airflow during sleep. Airflow obstruction arises when the muscles in the back of the throat fail to keep the airway open. OSA is characterized by repetitive pauses in breathing during sleep, despite the effort to breathe, and is usually associated with a reduction in blood oxygen saturation (...) . These pauses in breathing, called apneas, typically last 20 to 40 seconds. Hypopnea involves episodes of overly shallow breathing or an abnormally low respiratory rate. Hypopnea differs from apnea in that there remains some flow of air. Untreated OSA is associated with symptoms of sleep deprivation and excessive sleepiness, cognitive dysfunction, diminished quality of life and productivity, sexual dysfunction, mood changes, increased accident risk, and cardiovascular disease and stroke. OSA has

2011 Health Technology Assessment (HTA) Database.

382. [Home diagnosis of obstructive sleep apnea in children]

[Home diagnosis of obstructive sleep apnea in children] Diagnostic a domicile de l'apnee obstructive du sommeil chez l'enfant [Home diagnosis of obstructive sleep apnea in children] Diagnostic a domicile de l'apnee obstructive du sommeil chez l'enfant [Home diagnosis of obstructive sleep apnea in children] Lobe C Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made (...) for the HTA database. Citation Lobe C. Diagnostic a domicile de l'apnee obstructive du sommeil chez l'enfant. [Home diagnosis of obstructive sleep apnea in children] Montreal: Institut national d'excellence en sante et en services sociaux (INESSS). Volume 7(5). 2011 Authors' objectives

This report is a systematic review of the efficacy of portable devices for diagnosing OSA in children compared to that of the reference standard test, laboratory PSG. This report also presents an overview of the current

2011 Health Technology Assessment (HTA) Database.

383. CPAP for the metabolic syndrome in patients with obstructive sleep apnea. Full Text available with Trip Pro

CPAP for the metabolic syndrome in patients with obstructive sleep apnea. Obstructive sleep apnea is associated with an increased prevalence of the metabolic syndrome and its components. It is unclear whether treatment of obstructive sleep apnea syndrome with continuous positive airway pressure (CPAP) would modify these outcomes.In our double-blind, placebo-controlled trial, we randomly assigned patients with obstructive sleep apnea syndrome to undergo 3 months of therapeutic CPAP followed by 3 (...) CPAP therapy first, intolerance to CPAP developed in 2 others, and another patient declined to continue sham CPAP.In patients with moderate-to-severe obstructive sleep apnea syndrome, 3 months of CPAP therapy lowers blood pressure and partially reverses metabolic abnormalities. (Funded by Pfizer; ClinicalTrials.gov number, NCT00694616.).

2011 NEJM Controlled trial quality: predicted high

384. Nasal continuous positive airway pressure (nCPAP) treatment for obstructive sleep apnea, road traffic accidents and driving simulator performance: a meta-analysis

Nasal continuous positive airway pressure (nCPAP) treatment for obstructive sleep apnea, road traffic accidents and driving simulator performance: a meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2011 DARE.

385. Longer term effects of very low energy diet on obstructive sleep apnoea in cohort derived from randomised controlled trial: prospective observational follow-up study. Full Text available with Trip Pro

30-65 with body mass index (BMI) 30-40 and moderate to severe obstructive sleep apnoea defined as an apnoea-hypopnoea index ≥ 15 (events/hour), all treated with continuous positive airway pressure.A one year weight loss programme, consisting of an initial very low energy diet for nine weeks (seven weeks of 2.3 MJ/day and two weeks of gradual introduction of normal food) followed by a weight loss maintenance programme.Apnoea-hypopnoea index, the main index for severity of obstructive sleep apnoea (...) ; both P<0.001). After one year the apnoea-hypopnoea index had improved by -17 events/hour (-13 to -21) and body weight by -12 kg (-10 to -14) compared with baseline (both P<0.001). Patients with severe obstructive sleep apnoea at baseline had greater improvements in apnoea-hypopnoea index (-25 events/hour) compared with patients with moderate disease (-7 events/hour, P<0.001). At one year, 30/63 (48%, 95% confidence interval 35% to 60%) no longer required continuous positive airway pressure and 6/63

2011 BMJ Controlled trial quality: predicted high

387. Dexmedetomidine infusion for analgesia and prevention of emergence agitation in children with obstructive sleep apnea syndrome undergoing tonsillectomy and adenoidectomy Full Text available with Trip Pro

Dexmedetomidine infusion for analgesia and prevention of emergence agitation in children with obstructive sleep apnea syndrome undergoing tonsillectomy and adenoidectomy Dexmedetomidine, a specific α(2) agonist, has an analgesic-sparing effect and reduces emergence agitation. We compared an intraoperative dexmedetomidine infusion with bolus fentanyl to reduce perioperative opioid use and decrease emergence agitation in children with obstructive sleep apnea syndrome undergoing adenotonsillectomy (...) (T&A).One hundred twenty-two patients with obstructive sleep apnea syndrome undergoing T&A, ages 2 to 10 years, completed this prospective, randomized, U.S. Food and Drug Administration-approved study. After mask induction with sevoflurane, group D received IV dexmedetomidine 2 μg · kg(-1) over 10 minutes, followed by 0.7 μg · kg(-1) · h(-1), and group F received IV fentanyl bolus 1 μg · kg(-1). Anesthesia was maintained with sevoflurane, oxygen, and nitrous oxide. Fentanyl 0.5 to 1 μg · kg(-1

2010 EvidenceUpdates Controlled trial quality: uncertain

388. Comparison of continuous positive airway pressure and valsartan in hypertensive patients with sleep apnea (Abstract)

Comparison of continuous positive airway pressure and valsartan in hypertensive patients with sleep apnea Randomized controlled trials (RCTs) have shown that continuous positive airway pressure (CPAP) treatment of obstructive sleep apnea (OSA) reduces blood pressure (BP). CPAP treatment has never been compared with antihypertensive medications in an RCT.To assess the respective efficacy of CPAP and valsartan in reducing BP in hypertensive patients with OSA never treated for either condition.In (...) this 8-week randomized controlled crossover trial, 23 hypertensive patients (office systolic BP/diastolic BP: 155 ± 14/102 ± 11 mm Hg) with OSA (age, 57 ± 8 yr; body mass index, 28 ± 5 kg/m(2); apnea-hypopnea index, 29 ± 18/h) were randomized first to either CPAP or valsartan (160 mg). The second 8-week period consisted of the alternative treatment (crossover) after a 4-week washout period.Office BP and 24-hour BP were measured before and at the end of the two active treatment periods. Twenty-four

2010 EvidenceUpdates Controlled trial quality: uncertain

389. Inconclusive evidence on the efficacy of different interventions for obstructive sleep apnea in children

that is defined as a “disorder of breathing during sleep characterized by prolonged partial upper airway obstruction and/or intermittent complete obstruction that disrupts normal ventilation during sleep and normal sleep patterns”. OSA can affect children of all ages, although preschool-aged children are the most affected. If left untreated, children are at risk of neurocognitive deficits and can result in serious morbidity. Nocturnal polysomnography (sleep study) is the standard for diagnosis to quantitate (...) ventilatory and sleep abnormalities. Currently, adenotonsillectomy is the first line of treatment for most children.1 1 American Academy of Pediatrics, Section on Pediatric Pulmonology, Subcommittee on Obstructive Sleep Apnea Syndrome. Clinical Practice Guideline: Diagnosis and Management of Childhood Obstructive Sleep Apnea Syndrome. Pediatrics. 2002; 109(4):704-712. Strengths and Weaknesses of the Systematic Review: The review used accepted methods to identify and select RCT studies. There were

2010 ADA Center for Evidence-Based Dentistry

390. Inconclusive evidence on the efficacy of different interventions for obstructive sleep apnea in children

that is defined as a “disorder of breathing during sleep characterized by prolonged partial upper airway obstruction and/or intermittent complete obstruction that disrupts normal ventilation during sleep and normal sleep patterns”. OSA can affect children of all ages, although preschool-aged children are the most affected. If left untreated, children are at risk of neurocognitive deficits and can result in serious morbidity. Nocturnal polysomnography (sleep study) is the standard for diagnosis to quantitate (...) ventilatory and sleep abnormalities. Currently, adenotonsillectomy is the first line of treatment for most children.1 1 American Academy of Pediatrics, Section on Pediatric Pulmonology, Subcommittee on Obstructive Sleep Apnea Syndrome. Clinical Practice Guideline: Diagnosis and Management of Childhood Obstructive Sleep Apnea Syndrome. Pediatrics. 2002; 109(4):704-712. Strengths and Weaknesses of the Systematic Review: The review used accepted methods to identify and select RCT studies. There were

2010 ADA Center for Evidence-Based Dentistry

391. Inconclusive evidence on the efficacy of different interventions for obstructive sleep apnea in children

that is defined as a “disorder of breathing during sleep characterized by prolonged partial upper airway obstruction and/or intermittent complete obstruction that disrupts normal ventilation during sleep and normal sleep patterns”. OSA can affect children of all ages, although preschool-aged children are the most affected. If left untreated, children are at risk of neurocognitive deficits and can result in serious morbidity. Nocturnal polysomnography (sleep study) is the standard for diagnosis to quantitate (...) ventilatory and sleep abnormalities. Currently, adenotonsillectomy is the first line of treatment for most children.1 1 American Academy of Pediatrics, Section on Pediatric Pulmonology, Subcommittee on Obstructive Sleep Apnea Syndrome. Clinical Practice Guideline: Diagnosis and Management of Childhood Obstructive Sleep Apnea Syndrome. Pediatrics. 2002; 109(4):704-712. Strengths and Weaknesses of the Systematic Review: The review used accepted methods to identify and select RCT studies. There were

2010 ADA Center for Evidence-Based Dentistry

392. Effectiveness of acupressure for residents of long-term care facilities with insomnia: a randomized controlled trial (Abstract)

Effectiveness of acupressure for residents of long-term care facilities with insomnia: a randomized controlled trial Acupressure on the Shenmen point (indexed as HT7) can improve insomnia, but there has been no longitudinal study to evaluate its efficacy for residents of long-term care facilities. No evidence from the existing literature indicates how long its efficacy can be maintained after stopping acupressure.The aim of this study was to evaluate the effectiveness of acupressure (...) on the Shenmen point for residents of long-term care facilities with insomnia.Fifty residents with insomnia in long-term care facilities were enrolled in a randomized controlled trial, with 25 participants allocated to the experimental group and 25 participants to the control group. For a 5-week period, the experimental group received standard acupressure on the HT7 points of both wrists, whereas the control group received only light touch on the same places. Insomnia was measured with the Athens Insomnia

2010 EvidenceUpdates Controlled trial quality: uncertain

393. Continuous positive airway pressure titration for obstructive sleep apnoea: automatic versus manual titration Full Text available with Trip Pro

Continuous positive airway pressure titration for obstructive sleep apnoea: automatic versus manual titration Manual laboratory continuous positive airway pressure (CPAP) titration for obstructive sleep apnoea (OSA) is costly, time intensive and delays access to treatment. Automatic positive airway pressure (APAP) titration has the potential to reduce cost and improve access to treatment. The aim of this study was to assess the clinical efficacy and costs of APAP titration compared with manual (...) titration in moderate-severe OSA.Patients with moderate-severe OSA (apnoea/hypopnoea index >15 and Epworth Sleepiness Score > or = 8) who were free of co-morbidities that could impair APAP titration were eligible. 249 participants were randomised to manual titration, home APAP or laboratory APAP titration to determine a fixed pressure for CPAP. Clinical and direct cost outcomes were assessed after 4 weeks of treatment.Average nightly CPAP use, subjective sleepiness, SF36 quality of life, Trails A and B

2010 EvidenceUpdates Controlled trial quality: uncertain

394. Noninvasive ventilation immediately after extubation improves lung function in morbidly obese patients with obstructive sleep apnea undergoing laparoscopic bariatric surgery Full Text available with Trip Pro

Noninvasive ventilation immediately after extubation improves lung function in morbidly obese patients with obstructive sleep apnea undergoing laparoscopic bariatric surgery Noninvasive positive pressure ventilation (NIPPV) may improve postoperative lung function and reduce postoperative complications in patients undergoing abdominal surgery. The purpose of our study was to determine whether the timing of postoperative NIPPV affects lung function 1 day postoperatively.Forty morbidly obese (...) patients with known obstructive sleep apnea undergoing laparoscopic bariatric surgery with standardized anesthesia care were randomly assigned to receive NIPPV immediately after tracheal extubation (immediate group) or supplemental oxygen (standard group). All patients had continuous positive airway pressure initiated 30 minutes after extubation in the postanesthesia care unit (PACU) via identical noninvasive ventilators. Spirometry was performed by a blinded observer in the perioperative holding area

2010 EvidenceUpdates Controlled trial quality: uncertain

395. Derivation and validation of a simple perioperative sleep apnea prediction score (Abstract)

Derivation and validation of a simple perioperative sleep apnea prediction score Obstructive sleep apnea (OSA) is a largely underdiagnosed, common condition, which is important to diagnose preoperatively because it has implications for perioperative management. Our purpose in this study was to identify independent clinical predictors of a diagnosis of OSA in a general surgical population, develop a perioperative sleep apnea prediction (P-SAP) score based on these variables, and validate the P

2010 EvidenceUpdates

396. Report of an EFNS task force on management of sleep disorders in neurologic disease (degenerative neurologic disorders and stroke).

Report of an EFNS task force on management of sleep disorders in neurologic disease (degenerative neurologic disorders and stroke). Guidelines and Measures | Agency for Healthcare Research & Quality HHS.gov Search ahrq.gov Search ahrq.gov Menu Topics A - Z Healthcare Delivery Latest available findings on quality of and access to health care Searchable database of AHRQ Grants, Working Papers & HHS Recovery Act Projects AHRQ Projects funded by the Patient-Centered Outcomes Research Trust Fund You

2010 European Federation of Neurological Societies

397. Severity of REM atonia loss in idiopathic REM sleep behavior disorder predicts Parkinson disease Full Text available with Trip Pro

Severity of REM atonia loss in idiopathic REM sleep behavior disorder predicts Parkinson disease Over 50% of persons with idiopathic REM sleep behavior disorder (RBD) will develop Parkinson disease (PD) or dementia. At present, there is no way to predict who will develop disease. Since polysomnography is performed in all patients with idiopathic RBD at diagnosis, there is an opportunity to analyze if baseline sleep variables predict eventual neurodegenerative disease.In a longitudinally studied (...) 41.0 +/- 6.0%, p = 0.002), and not in those who developed dementia (54.3 +/- 10.3, p = 0.28). There was no difference in phasic submental REM EMG activity between groups.In patients with REM sleep behavior disorder initially free of neurodegenerative disease, the severity of REM atonia loss on baseline polysomnogram predicts the development of Parkinson disease.

2010 EvidenceUpdates

398. Best Practice Guide for the Treatment of REM Sleep Behavior Disorder (RBD)

Best Practice Guide for the Treatment of REM Sleep Behavior Disorder (RBD) R. Nisha Aurora" /> JCSM - Best Practice Guide for the Treatment of REM Sleep Behavior Disorder (RBD) Search article archive here ADVERTISEMENT Current Issue: Volume: 15 Number: 03 Issue Navigator Volume 06 No. 01 .9-10 Charles F. Reynolds III, M.D. 1 ; Susan Redline, M.D. 2 ; for the DSM-V Sleep-Wake Disorders Workgroup and Advisors* .11-17 Nathaniel F. Watson, M.D., M.S. 1 ; Dedra Buchwald, M.D. 2 ; Michael V. Vitiello (...) , of the article without the written permission of the AASM. Further, purchase does not permit the posting of article text on an online forum or website. E-mail Share Slides Please login to download PDF Subscribers can download and print full articles from current and past issues of the JCSM Not a subscriber? and receive a subscription to JCSM with your membership Special Articles Best Practice Guide for the Treatment of REM Sleep Behavior Disorder (RBD) Standards of Practice Committee: R. Nisha Aurora, M.D. 1

2010 American Academy of Sleep Medicine

399. Practice Parameters for the Surgical Modifications of the Upper Airway for Obstructive Sleep Apnea in Adults

. A review of neuroimaging in obstructive sleep apnea. J Clin Sleep Med 2006;2:461-71. 16. Shahar E, Whitney C, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001;163:19-25. 17. Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular out- comes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet (...) , MI; 7 Penn State University Hershey Medical Center, Hershey, P A and University of Louisville School of Medicine, Louisville, KY; 8 Children’ s Hospital of NY – Presbyterian, Columbia University Medical Center, New York, NY; 9 Mayo Clinic, Rochester, MN; 10 Sleep Disorders Center, University of California, San Francisco, San Francisco, CA Background: Practice parameters for the treatment of obstructive sleep apnea syndrome (OSAS) in adults by surgical modification of the upper airway were first

2010 American Academy of Sleep Medicine

400. Unattended Sleep Studies in the Diagnosis of Obstructive Sleep Apnoea

number of studies, MSAC found Level 2, 3 and 4 unattended sleep settings to be as safe as the currently funded Level 1 studies (which have trained staff in attendance) for obstructive sleep apnoea (OSA), except in the case of young children or patients with cognitive disorders. MSAC concluded that the more physiological parameters that are measured, the more accurate the diagnostic performance of the service, with performance decreasing from Level 1 (thirteen parameters) to Level 4 (one to two (...) Unattended Sleep Studies in the Diagnosis of Obstructive Sleep Apnoea Medical Services Advisory Committee Public Summary Document Application No. 1130 – Unattended Sleep Studies in the Diagnosis and Reassessment of Obstructive Sleep Apnoea Applicants: Australasian Sleep Association / Thoracic Society of Australia and New Zealand Healthy Workplace Solutions Pty Ltd, trading as Healthy Sleep Solutions Date of MSAC consideration: 48th MSAC meeting, 29-30 March 2010 1. Purpose of Application In May

2010 Medical Services Advisory Committee